-
J166817-250mgProduct Describtion:JQ1 is a member of the triazolo-diazepine compound family, which functions as a pan-BET (bromodomain and extra-terminal motif) family inhibitor. JQ1 is known to suppress cell proliferation and therefore, can be used as a
-
J166817-25mgProduct Describtion:JQ1 is a member of the triazolo-diazepine compound family, which functions as a pan-BET (bromodomain and extra-terminal motif) family inhibitor. JQ1 is known to suppress cell proliferation and therefore, can be used as a
-
J166817-50mgProduct Describtion:JQ1 is a member of the triazolo-diazepine compound family, which functions as a pan-BET (bromodomain and extra-terminal motif) family inhibitor. JQ1 is known to suppress cell proliferation and therefore, can be used as a
-
J166817-5mgProduct Describtion:JQ1 is a member of the triazolo-diazepine compound family, which functions as a pan-BET (bromodomain and extra-terminal motif) family inhibitor. JQ1 is known to suppress cell proliferation and therefore, can be used as a
-
J409150-1mlInformation(+)-JQ1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for BRD4(1/2) in cell-free assays, binding to all bromodomains of the BET family, but not to bromodomains outside the BET family. (+)-JQ1 suppresses cell proliferation via
-
J286888-1g(+)-JQ1 carboxylic acid.
-
J286888-250mg(+)-JQ1 carboxylic acid.
-
J286888-50mg(+)-JQ1 carboxylic acid.
-
J422464-1ml(+)-JQ1 carboxylic acid.
-
J287625-100mgFunctionalized BET bromodomain inhibitor: 'click' target ligand for PROTACs.
-
J287625-10mgFunctionalized BET bromodomain inhibitor: 'click' target ligand for PROTACs.
-
J287625-25mgFunctionalized BET bromodomain inhibitor: 'click' target ligand for PROTACs.